Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation

被引:16
|
作者
Simoes, Eric A. F. [1 ,2 ]
Anderson, Evan J. [3 ,4 ]
Wu, Xionghua [5 ]
Ambrose, Christopher S. [6 ]
机构
[1] Univ Colorado, Sch Med, Colorado Sch Publ Hlth, Aurora, CO 80045 USA
[2] Childrens Hosp Colorado, Aurora, CO 80045 USA
[3] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[4] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
[5] MedImmune, Dept Biostat, Gaithersburg, MD USA
[6] AstraZeneca, Gaithersburg, MD 20878 USA
来源
PLOS ONE | 2016年 / 11卷 / 11期
关键词
REQUIRING HOSPITALIZATION; INFECTION; IMMUNOPROPHYLAXIS; BRONCHIOLITIS; RISK;
D O I
10.1371/journal.pone.0166226
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective To estimate the incidence of respiratory syncytial virus (RSV) disease as a function of chronologic age and exposure to young children in US preterm infants. Methods In the RSV Respiratory Events among Preterm Infants Outcomes and Risk Tracking (REPORT) study, preterm infants born at 32-35 weeks gestational age (wGA) were enrolled from 188 US clinics and followed September-May of 2009-2010 or 2010-2011. Infants with medically-attended acute respiratory illness had nasal/pharyngeal swabs collected for viral testing. Results of RSV tests conducted during routine clinical care were also collected. Event rates during November-March were modeled as a function of chronologic age and birth month using Poisson regression and adjusting for other covariates. Rates were calculated overall and for infants with and without exposure to young siblings or daycare attendance. Of 3317 infants screened, 1646 were enrolled as a consecutive sample. Infants with chronic lung disease of prematurity, hemodynamically significant congenital heart disease, life expectancy < 6 months, or receiving or being considered for RSV immunoprophylaxis were excluded. 84% of patients completed the study. Demographics of the enrolled cohort were generally similar to those of US infants born at 32-35 wGA; infants 32-34 wGA, Hispanic infants, and infants of less-educated mothers were under-represented. Results Among 1642 evaluable infants, outpatient RSV lower respiratory illness incidence was highest at older ages, whereas RSV hospitalization and intensive care unit (ICU) admission were highest at younger ages. In all instances, young child exposure was associated with higher RSV incidence. The highest RSV hospitalization and ICU rates occurred among February-born infants with young child exposure, at 19.0 (95% CI, 13.5-27.0) and 6.5 (95% CI, 5.6-7.6) per 100 infant-seasons, respectively. Conclusions Preterm infants have a substantially elevated risk of RSV disease. Young age and exposure to other young children identify those at greatest risk of severe RSV disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32-35 Weeks Gestation Not Receiving Immunoprophylaxis
    Ambrose, Christopher S.
    Anderson, Evan J.
    Simoes, Eric A. F.
    Wu, Xionghua
    Elhefni, Hanaa
    Park, C. Lucy
    Sifakis, Frangiscos
    Groothuis, Jessie R.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 576 - 582
  • [2] Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32-35 Weeks Gestational Age
    Franklin, Jeremy A.
    Anderson, Evan J.
    Wu, Xionghua
    Ambrose, Christopher S.
    Simoes, Eric A. F.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [3] Estimating Respiratory Syncytial Virus-associated Hospitalization in the First Year of Life Among Infants Born at 32-35 Weeks of Gestation
    Ryan, Venessa M. J.
    Langley, Joanne M.
    Dodds, Linda
    Andreou, Pantelis
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) : 851 - 855
  • [4] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Rohan C. Parikh
    Kimmie K. McLaurin
    Andrea V. Margulis
    Josephine Mauskopf
    Christopher S. Ambrose
    Melissa Pavilack
    Sean D. Candrilli
    [J]. Infectious Diseases and Therapy, 2017, 6 : 477 - 486
  • [5] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Parikh, Rohan C.
    McLaurin, Kimmie K.
    Margulis, Andrea V.
    Mauskopf, Josephine
    Ambrose, Christopher S.
    Pavilack, Melissa
    Candrilli, Sean D.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2017, 6 (04) : 477 - 486
  • [6] Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
    Anderson, Evan J.
    Carbonell-Estrany, Xavier
    Blanken, Maarten
    Lanari, Marcello
    Sheridan-Pereira, Margaret
    Rodgers-Gray, Barry
    Fullarton, John
    Rouffiac, Elisabeth
    Vo, Pamela
    Notario, Gerard
    Campbell, Fiona
    Paes, Bosco
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (02) : 160 - 167
  • [7] Completed Weeks of Gestation and Risk of Respiratory Syncytial Virus in Late Preterm Infants
    Chabra, Shilpi
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (12) : 1227 - 1227
  • [8] Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier -: Hospitalization and economic implications of prophylaxis
    Stevens, TP
    Sinkin, RA
    Hall, CB
    Maniscalco, WM
    McConnochie, KM
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (01): : 55 - 61
  • [9] COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN PRETERM INFANTS 29-35 WEEKS' GESTATION
    Yu, T.
    Padula, W.
    Yieh, L.
    Gong, C. L.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S412 - S412
  • [10] Intensive Care Unit Admission Rates for Respiratory Syncytial Virus Infection as a Function of Age in Preterm Infants Born at 32-35-week Gestation and Not Receiving Immunoprophylaxis
    Simoes, Eric A. F.
    Ambrose, Christopher S.
    Wu, Xionghua
    Anderson, Evan J.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (03) : 331 - 331